Sign In
Buy ECOR
$6.09
-0.205 (-3.26%)
At Close: Jul 31, 2026
electroCore, Inc. (ECOR) Q4 2025 Earnings Call Transcript
08:02pm, Thursday, 19'th Mar 2026
electroCore, Inc. (ECOR) Q4 2025 Earnings Call Transcript
electroCore, Inc. (ECOR) Reports Q4 Loss, Lags Revenue Estimates
06:46pm, Thursday, 19'th Mar 2026
electroCore, Inc. (ECOR) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to a loss of $0.4 per share a year ago.
electroCore Announces Full Year 2025 Financial Results and Organizational Changes
04:05pm, Thursday, 19'th Mar 2026
Record f ull year 2025 net sales of $ 32.0 , an increase of 27% over $25.2 million for the full year 2024 driven by 25% annual growth in our U.S. prescription business and 97% increase in general
Ecora Royalties emerges as defensive commodity play as Iran conflict roils mining sector
12:22pm, Wednesday, 18'th Mar 2026
The royalty company's structure shields investors from rising fuel and chemical costs that are squeezing conventional miners RBC Capital Markets has highlighted Ecora Royalties PLC (LSE:ECOR, TSX:ECOR
electroCore to Participate at the 38th Annual Roth Conference
08:00am, Tuesday, 10'th Mar 2026
ROCKAWAY, N.J., March 10, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a bioelectronic medicine and wellness company, announced today that management will participate in the 38th Annual
electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2025, Financial Results on Thursday, March 19, 2026
08:00am, Monday, 09'th Mar 2026
ROCKAWAY, N.J., March 09, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will report financial resul
electroCore, Inc. (ECOR) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
11:01am, Wednesday, 04'th Mar 2026
electroCore (ECOR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ecora Royalties hits inflexion point as base metals revenue surges 150%; shares up 140% in a year
09:19am, Wednesday, 04'th Mar 2026
Critical minerals now account for 63% of portfolio contribution as the royalty company's pivot away from coal produces tangible results Ecora Royalties PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF, FRA:HGR) h
Ecora Royalties says "stellar performance" marks inflection point for its portfolio
03:42am, Wednesday, 28'th Jan 2026
Ecora Royalties PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF, FRA:HGR) has, in today's trading update for the fourth quarter, reported a total portfolio contribution of $57 million for the year ended 31 De
ROCKAWAY, N.J., Jan. 21, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or the “Company”), a bioelectronic technology company, today announced that Acacia Clinics and
electroCore Provides Preliminary Full-Year 2025 Business Update; Expects ~26% Revenue Growth to ~$31.8–$32.0 Million
08:00am, Tuesday, 20'th Jan 2026
ROCKAWAY, N.J., Jan. 20, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or the “Company”), a bioelectronic technology company, today provided select unaudited prelimi
Financial Survey: Telomir Pharmaceuticals (NASDAQ:TELO) versus electroCore (NASDAQ:ECOR)
02:24am, Sunday, 18'th Jan 2026
electroCore (NASDAQ: ECOR - Get Free Report) and Telomir Pharmaceuticals (NASDAQ: TELO - Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the
electroCore (NASDAQ:ECOR) Trading Up 1.4% – What’s Next?
04:47am, Sunday, 28'th Dec 2025
Shares of electroCore, Inc. (NASDAQ: ECOR - Get Free Report) traded up 1.4% on Friday. The stock traded as high as $4.96 and last traded at $4.95. 19,108 shares were traded during mid-day trading, a d
electroCore, Inc. (ECOR) Discusses Neuromodulation Platform, Business Evolution, and Strategic Priorities Transcript
12:36am, Friday, 26'th Dec 2025
electroCore, Inc. (ECOR) Discusses Neuromodulation Platform, Business Evolution, and Strategic Priorities Transcript
TAC-STIM Demonstrates Significant Performance Improvements in Active-Duty United States Air Force Airmen
08:00am, Tuesday, 02'nd Dec 2025
ROCKAWAY, N.J., Dec. 02, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or the “Company”), a bioelectronic technology company, today announced the publication of a pe
